Functional significance of vascular endothelial growth factor and its receptor (receptor-1) in various lung cancer types

Clinical Biochemistry

Volumn 37, Issue 9, 2004, Pages 840-845

  Ilhan, Nevin ^a,c   Ilhan, Necip ^a   Deveci, Figen ^b  

^a Dept of Biochem and Clin Biochem ^*  (Turkey)

^b FIRAT UNIVERSITY   (Turkey)

^c FIRAT UNIVERSITY   (Turkey)

Author keywords

Lung cancer; sVEGFR 1; VEGF

Indexed keywords

VASCULOTROPIN RECEPTOR 1;

ADULT; AGED; ANGIOGENESIS; ARTICLE; CLINICAL ARTICLE; CONTROLLED STUDY; ENDOTHELIUM CELL; FEMALE; HUMAN; LUNG CANCER; MALE; METASTASIS; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; STATISTICAL SIGNIFICANCE; TUMOR GROWTH;

AGED; AGED, 80 AND OVER; FEMALE; HUMANS; LUNG NEOPLASMS; MALE; MIDDLE AGED; STATISTICS, NONPARAMETRIC; VASCULAR ENDOTHELIAL GROWTH FACTOR A; VASCULAR ENDOTHELIAL GROWTH FACTOR RECEPTOR-1;

EID: 4344611148     PISSN: 00099120     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.clinbiochem.2004.03.012     Document Type: Article

References (39)

1. Dvorak H.F., Brown L.F., Detmaar M., Dvorak A.M. Vascular permeability factor/vascular endothelial growth factor, microvascular hyperpermeability, and angiogenesis. Am. J. Pathol. 146:1995;1029-1039
2. Folkman J. What is the evidence that tumors are angiogenesis-dependent? J. Natl. Cancer Inst. 82:1991;4-6
3. Folkman J. Clinical applications of research on angiogenesis. N. Engl. J. Med. 333:1995;1757-1763
4. Hanahan D., Folkman J. Patterns and emerging mechanisms of the angiogenic switch during tumorigenesis. Cell. 86:1996;353-364
5. de Vries C., Escobedo J.A., Ueno H., Houck K., Ferrara N., Williams L.T. The fms-like tyrosine kinase, a receptor for vascular endothelial growth factor. Science. 255:1992;989-991
6. Shibuya M., Yamaguchi S., Yamane A., et al. Nucleotide sequence and expression of a novel human receptor-type tyrosine kinase gene (flt) closely related to the fms family. Oncogene. 5:1990;519-524
7. Terman B.I., Dougher-Vermazen M., Carrion M.E., et al. Identification of the KDR tyrosine kinase as a receptor for vascular endothelial cell growth factor. Biochem. Biophys. Res. Commun. 187:1992;1579-1586
8. Wang J.F., Zhang X.F., Groopman J.E. Stimulation of beta 1 integrin induces tyrosine phosphorylation of vascular endothelial growth factor receptor-3 and modulates cell migration. J. Biol. Chem. 276:2001;41950-41957
9. Achen M.G., Jeltsch M., Kukk E., et al. Vascular endothelial growth factor D (VEGF-D) is a ligand for the tyrosine kinases VEGF receptor 2 (Flk1) and VEGF receptor 3 (Flt4). Proc. Natl. Acad. Sci. 95:1998;548-553
10. Soker S., Takashima S., Miao H.Q., Neufeld G., Klagsbrun M. Neuropilin-1 is expressed by endothelial and tumor cells as an isoform-specific receptor for vascular endothelial growth factor. Cell. 92:1998;735-745
11. Veikkola T., Karkkainen M., Claesson-Welsh L., Alitalo K. Regulation of angiogenesis via vascular endothelial growth factor receptors. Cancer Res. 60:2000;203-212
12. Barleon B., Sozzani S., Zhou D., Weich H.A., Mantovani A., Marme D. Migration of human monocytes in response to vascular endothelial growth factor (VEGF) is mediated via the VEGF receptor flt-1. Blood. 87:1996;3336-3343
13. Clauss M., Weich H., Breier G., et al. The vascular endothelial growth factor receptor Flt-1 mediates biological activities. Implications for a functional role of placenta growth factor in monocyte activation and chemotaxis. J. Biol. Chem. 271:1996;17629-17634
14. Wang D., Donner D.B., Warren R.S. Homeostatic modulation of cell surface KDR and Flt1 expression and expression of the vascular endothelial cell growth factor (VEGF) receptor mRNAs by VEGF. J. Biol. Chem. 275:2000;15905-15911
15. Hornig C., Behn T., Bartsch W., Yayon A., Weich H.A. Detection and quantification of complexed and free soluble human vascular endothelial growth factor receptor-1 (sVEGFR-1) by ELISA. J. Immunol. Methods. 226(24):1999;169-177
16. Hornig C., Barleon B., Ahmad S., Vuorela P., Ahmed A., Weich H.A. Release and complex formation of soluble VEGFR-1 from endothelial cells and biological fluids. Lab. Invest. 80:2000;443-454
17. Kendall R.L., Wang G., Thomas K.A. Identification of a natural soluble form of the vascular endothelial growth factor receptor, FLT-1, and its heterodimerization with KDR. Biochem. Biophys. Res. Commun. 226:1996;324-328
18. Verheul H.M.W., Hoekman K., Luykx-de Bakker S., et al. Platelet: transporter of vascular endothelial growth factor. Clin. Cancer Res. 3:1997;2187-2190
19. Mohle R., Green D., Moore M.A., et al. Constitutive production and thrombin-induced release of vascular endothelial growth factor by human megakaryocytes and platelets. Proc. Natl. Acad. Sci. 94:1997;663-668
20. Pinedo H.M., Verheul H.M.W., D'Amato R.J.D., Folkman J. Involvement of platelets in tumour angiogenesis. Lancet. 352:1998;1775-1777
21. Klagsbrun M., D'Amore P.A. Vascular endothelial growth factor and its receptors. Cytokine Growth Factor Rev. 7:1996;259-270
22. Barleon B., Reusch P., Totzke F., et al. Soluble VEGFR-1 secreted by endothelial cells and monocytes is present in human serum and plasma from healthy donors. Angiogenesis. 4:2001;143-154
23. Freeman M.R., Schneck F.X., Gagnon M.L., et al. Peripheral blood T lymphocytes and lymphocytes infiltrating human cancers express vascular endothelial growth factor: a potential role for T cells in angiogenesis. Cancer Res. 55:1995;4140-4145
24. Salven P., Orpana A., Joensuu H. Leukocytes and platelets of patients with cancer contain high levels of vascular endothelial growth factor. Clin. Cancer Res. 5:1999;487-491
25. Takanami I., Tanaka F., Hashizume T., Kodaira S. Tumor angiogenesis in pulmonary adenocarcinomas: relationship with basic fibroblast growth factor, its receptor, and survival. Neoplasma. 44(5):1997;295-298
26. Johnson R.A., Roodman G.D. Hematologic manifestations of malignancy. Dis. Mon. 35:1989;721-768
27. World Health Organisation Histologic typing of lung tumors. International classification of tumors. 1991;1 World Health Organisation, Geneva, Switzerland
28. Mountain C.F. Revisions in the international system for staging lung cancer. Chest. 111:1997;1710-1717
29. Yamamoto Y., Toi M., Kondo S., et al. Concentrations of vascular endothelial growth factor in the sera of normal controls and cancer patients. Clin. Cancer Res. 2:1996;821-826
30. Dirix L.Y., Vermeulen P.B., Pawinski A., et al. Elevated levels of the angiogenic cytokines basic fibroblast growth factor and vascular endothelial growth factor in sera of cancer patients. Br. J. Cancer. 76:1997;238-243
31. Yamamoto S., Konishi I., Mandai M., et al. Expression of vascular endothelial growth factor (VEGF) in epithelial ovarian neoplasms: correlation with clinicopathology and patient survival, and analysis of serum VEGF levels. Br. J. Cancer. 76:1997;1221-1227
32. Jung Y.D., Mansfield P.F., Akagi M., et al. Effects of combination anti-vascular endothelial growth factor receptor and anti-epidermal growth factor receptor therapies on the growth of gastric cancer in a nude mouse model. Eur. J. Cancer. 38:2002;1133-1140
33. Adini A., Kornaga T., Firoozbakht F., Benjamin L.E. Placental growth factor is a survival factor for tumor endothelial cells and macrophages. Cancer Res. 62:2002;2749-2752
34. Saijo Y., Tanaka M., Miki M., et al. Proinflammatory cytokine IL-1 beta promotes tumor growth of Lewis lung carcinoma by induction of angiogenic factors: in vivo analysis of tumor-stromal interaction. J. Immunol. 169:2002;469-475
35. Hefler L., Tempfer C., Obermair A., et al. Serum concentrations of vascular endothelial growth factor in vulvar cancer. Clin. Cancer Res. 5:1999;2806-2809
36. O'Byrne K.J., Dobbs N., Propper D., Smith K., Harris A.L. Vascular endothelial growth factor platelet counts, and prognosis in renal cancer. Lancet. 353:1999;1494-149532
37. Salgado R., Vermeulen P.B., Benoy I., et al. Platelet number and interleukin-6 correlate with VEGF but not with bFGF serum levels of advanced cancer patients. Br. J. Cancer. 80:1999;892-897
38. Wartiovaara U., Salven P., Mikkola H., et al. Peripheral blood platelets express VEGF-C and VEGF which are released during platelet activation. Thromb. Haemost. 80:1998;171-175
39. Takano S., Yoshii Y., Kondo S., et al. Concentration of vascular endothelial growth factor in the serum and tumor tissue of brain tumor patients. Cancer Res. 56:1996;2185-2190